99 results
PRE 14A
LYRA
Lyra Therapeutics Inc
19 Apr 24
Preliminary proxy
4:20pm
and a director since 2013 until its acquisition by Sanofi in November 2021. Prior to joining Kadmon as an employee, Dr. Waksal served as President and Sole … decrease in the market value of the Company’s equity securities, or that may cause an officer, director, or employee to no longer have the same objectives
S-8
LYRA
Lyra Therapeutics Inc
22 Mar 24
Registration of securities for employees
7:41am
and permit us to secure insurance on behalf of any officer, director, employee or agent for any liability arising out of his or her action in that capacity … of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee
8-K
EX-99.1
9budt9u6lvso 2kj
21 Mar 24
Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4:12pm
8-K
EX-3.1
nt7b2p pz7ov
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
EX-99.1
pi4we
7 Nov 23
Lyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:09pm
8-K
EX-1.1
e6zi3i9k1fwi75aaz
1 Sep 23
Entry into a Material Definitive Agreement
4:03pm
424B5
lavwg slazx5m8cuao
1 Sep 23
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
iyq5ox3m2 xx
8 Aug 23
Lyra Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:03pm
8-K
EX-10.1
icpyaqs28ffsc ter
31 May 23
Lyra Therapeutics Announces $50.0 Million Private Placement
5:30pm
8-K
EX-99.1
wzbt 9gnzdmuw
12 May 23
Lyra Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:09am